137 studies found for:    Vaginal Cancer: Clinical Trials
Show Display Options
Rank Status Study
21 Completed Care of Cancer Patients With Bowel Injury Caused by Radiation Therapy to the Pelvis
Condition: Cancer
Interventions: Other: educational intervention;   Other: questionnaire administration;   Procedure: assessment of therapy complications;   Procedure: gastrointestinal complications management/prevention;   Procedure: management of therapy complications;   Procedure: quality-of-life assessment
22 Completed
Has Results
Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer
Conditions: Recurrent Cervical Cancer;   Recurrent Vaginal Cancer;   Stage IB Cervical Cancer;   Stage II Vaginal Cancer;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage III Cervical Cancer;   Stage III Vaginal Cancer;   Stage IVA Cervical Cancer;   Stage IVA Vaginal Cancer;   Stage IVB Cervical Cancer;   Stage IVB Vaginal Cancer;   Therapy-related Toxicity
Interventions: Drug: triapine;   Drug: cisplatin;   Radiation: external beam radiation therapy;   Procedure: quality-of-life assessment;   Other: questionnaire administration;   Radiation: fludeoxyglucose F 18;   Procedure: positron emission tomography;   Procedure: computed tomography
23 Recruiting Cisplatin and Radiation Therapy With or Without Triapine in Treating Patients With Previously Untreated Stage IB-IVA Cervical Cancer or Stage II-IVA Vaginal Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Cell Carcinoma;   Cervical Squamous Cell Carcinoma;   Stage IB Cervical Cancer;   Stage II Vaginal Cancer;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage III Vaginal Cancer;   Stage IIIA Cervical Cancer;   Stage IIIB Cervical Cancer;   Stage IVA Cervical Cancer;   Stage IVA Vaginal Cancer;   Vaginal Adenocarcinoma;   Vaginal Squamous Cell Carcinoma
Interventions: Drug: triapine;   Drug: cisplatin;   Radiation: external beam radiation therapy;   Radiation: brachytherapy;   Other: laboratory biomarker analysis
24 Completed Effectiveness of an Individualized Symptom Education Program (ISEP)
Conditions: Uterine Cancer;   Cervical Cancer;   Vaginal Cancer;   Vulvar Cancer
Intervention: Behavioral: Individualized Symptom Education
25 Recruiting Non-Hormonal Vaginal Moisturizer in Hormone-Receptor Positive Postmenopausal Cancer Survivors Experiencing Estrogen Deprivation Symptoms
Conditions: Breast Cancer;   Endometrial Cancer
Interventions: Other: HLA vaginal gel (HyaloGYN®),;   Behavioral: questionnaires
26 Completed Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer
Conditions: Cervical Cancer;   Vaginal Cancer
Intervention: Drug: paclitaxel
27 Completed Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery
Conditions: Cervical Cancer;   Endometrial Cancer;   Fallopian Tube Cancer;   Ovarian Cancer;   Sarcoma;   Vaginal Cancer;   Vulvar Cancer
Interventions: Drug: topotecan hydrochloride;   Other: pharmacological study
28 Completed Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis
Conditions: Bladder Cancer;   Cervical Cancer;   Endometrial Cancer;   Vaginal Cancer
Interventions: Drug: paclitaxel;   Drug: vinorelbine tartrate;   Radiation: radiation therapy
29 Completed Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer
Conditions: Cervical Cancer;   Endometrial Cancer;   Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer;   Sarcoma;   Vaginal Cancer;   Vulvar Cancer
Intervention: Drug: docetaxel
30 Active, not recruiting Psychosexual Intervention in Patients With Stage I-III Gynecologic Cancer
Conditions: Leydig Cell Tumor;   Ovarian Sarcoma;   Ovarian Stromal Cancer;   Stage I Gestational Trophoblastic Tumor;   Stage I Uterine Sarcoma;   Stage I Vaginal Cancer;   Stage I Vulvar Cancer;   Stage IA Cervical Cancer;   Stage IA Endometrial Carcinoma;   Stage IA Fallopian Tube Cancer;   Stage IA Ovarian Epithelial Cancer;   Stage IA Ovarian Germ Cell Tumor;   Stage IA Primary Peritoneal Cavity Cancer;   Stage IB Cervical Cancer;   Stage IB Endometrial Carcinoma;   Stage IB Fallopian Tube Cancer;   Stage IB Ovarian Epithelial Cancer;   Stage IB Ovarian Germ Cell Tumor;   Stage IB Primary Peritoneal Cavity Cancer;   Stage IC Fallopian Tube Cancer;   Stage IC Ovarian Epithelial Cancer;   Stage IC Ovarian Germ Cell Tumor;   Stage IC Primary Peritoneal Cavity Cancer;   Stage II Endometrial Carcinoma;   Stage II Gestational Trophoblastic Tumor;   Stage II Uterine Sarcoma;   Stage II Vaginal Cancer;   Stage II Vulvar Cancer;   Stage IIA Cervical Cancer;   Stage IIA Fallopian Tube Cancer;   Stage IIA Ovarian Epithelial Cancer;   Stage IIA Ovarian Germ Cell Tumor;   Stage IIA Primary Peritoneal Cavity Cancer;   Stage IIB Cervical Cancer;   Stage IIB Fallopian Tube Cancer;   Stage IIB Ovarian Epithelial Cancer;   Stage IIB Ovarian Germ Cell Tumor;   Stage IIB Primary Peritoneal Cavity Cancer;   Stage IIC Fallopian Tube Cancer;   Stage IIC Ovarian Epithelial Cancer;   Stage IIC Ovarian Germ Cell Tumor;   Stage IIC Primary Peritoneal Cavity Cancer;   Stage III Gestational Trophoblastic Tumor;   Stage III Uterine Sarcoma;   Stage III Vaginal Cancer;   Stage III Vulvar Cancer;   Stage IIIA Cervical Cancer;   Stage IIIA Endometrial Carcinoma;   Stage IIIA Fallopian Tube Cancer;   Stage IIIA Ovarian Epithelial Cancer;   Stage IIIA Ovarian Germ Cell Tumor;   Stage IIIA Primary Peritoneal Cavity Cancer;   Stage IIIB Cervical Cancer;   Stage IIIB Endometrial Carcinoma;   Stage IIIB Fallopian Tube Cancer;   Stage IIIB Ovarian Epithelial Cancer;   Stage IIIB Ovarian Germ Cell Tumor;   Stage IIIB Primary Peritoneal Cavity Cancer;   Stage IIIC Endometrial Carcinoma;   Stage IIIC Fallopian Tube Cancer;   Stage IIIC Ovarian Epithelial Cancer;   Stage IIIC Ovarian Germ Cell Tumor;   Stage IIIC Primary Peritoneal Cavity Cancer
Interventions: Other: questionnaire administration;   Procedure: quality-of-life assessment;   Other: behavioral, psychological or informational intervention
31 Withdrawn Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer
Conditions: Cervical Cancer;   Endometrial Cancer;   Ovarian Cancer;   Vaginal Cancer
Interventions: Drug: capecitabine;   Radiation: brachytherapy;   Radiation: radiation therapy
32 Completed Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis
Conditions: Cervical Cancer;   Colorectal Cancer;   Diarrhea;   Endometrial Cancer;   Fallopian Tube Cancer;   Ovarian Cancer;   Prostate Cancer;   Sarcoma;   Unspecified Adult Solid Tumor, Protocol Specific;   Vaginal Cancer;   Vulvar Cancer
Intervention: Drug: octreotide acetate
33 Unknown  Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer
Conditions: Cervical Cancer;   Endometrial Cancer;   Fallopian Tube Cancer;   Ovarian Cancer;   Sarcoma;   Vaginal Cancer;   Vulvar Cancer
Interventions: Dietary Supplement: therapeutic nutritional supplementation;   Procedure: standard follow-up care
34 Not yet recruiting Phone or Email Reminder in Increasing Vaginal Dilator Use in Patients With Gynecologic Cancers Undergoing Brachytherapy
Conditions: Cervical Cancer;   Endometrial Cancer;   Radiation Toxicity;   Vaginal Cancer
Interventions: Other: survey administration;   Other: computer-assisted intervention;   Behavioral: telephone-based intervention
35 Enrolling by invitation Randomized Trial of Vaginal Self Sampling for Human Papillomavirus (HPV)
Conditions: Human Papillomavirus Infection;   Cervical Intraepithelial Neoplasia
Interventions: Device: offer of vaginal self collection;   Other: 2nd reminder letter for Pap testing
36 Completed Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies
Conditions: Recurrent Cervical Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Vaginal Cancer;   Recurrent Vulvar Cancer;   Stage III Vaginal Cancer;   Stage IIIA Cervical Cancer;   Stage IIIA Ovarian Epithelial Cancer;   Stage IIIA Vulvar Cancer;   Stage IIIB Cervical Cancer;   Stage IIIB Ovarian Epithelial Cancer;   Stage IIIB Vulvar Cancer;   Stage IIIC Ovarian Epithelial Cancer;   Stage IIIC Vulvar Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IVA Cervical Cancer;   Stage IVA Vaginal Cancer;   Stage IVB Cervical Cancer;   Stage IVB Vaginal Cancer
Interventions: Drug: triapine;   Other: laboratory biomarker analysis;   Radiation: external beam radiation therapy;   Radiation: brachytherapy;   Drug: cisplatin;   Other: pharmacological study
37 Completed
Has Results
GARDASIL™ Study in Healthy Females Between 9 and 26 Years of Age in Sub-Saharan Africa (V501-046)
Condition: Papillomavirus Infections
Interventions: Biological: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (GARDASIL™);   Biological: Placebo
38 Completed
Has Results
Pilocarpine in Treating Vaginal Dryness in Patients With Breast Cancer
Conditions: Breast Cancer;   Vaginal Dryness
Interventions: Drug: pilocarpine hydrochloride;   Other: placebo
39 Completed MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma
Condition: Cancer
Intervention: Drug: entinostat
40 Completed Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer
Condition: Cancer
Interventions: Biological: trastuzumab;   Drug: tipifarnib

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years